Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy 01/20/2022 OBSERVATIONAL unchanged 1,679.85 0 Prospective Case Collection Study for New Mammography Technologies 01/20/2022 INTERVENTIONAL unchanged 1,679.85 0 Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer 01/20/2022 INTERVENTIONAL unchanged 1,679.85 0 T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors 01/20/2022 INTERVENTIONAL unchanged 1,679.85 0 Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line 01/21/2022 INTERVENTIONAL unchanged 1,678.85 0 RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis 01/21/2022 INTERVENTIONAL unchanged 1,678.85 0 Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes 01/24/2022 INTERVENTIONAL unchanged 1,675.85 0 Comparison of the Therapeutic Effects of VR and VR + Metformin in the Treatment of Cesarean Section Scar Defect 01/25/2022 INTERVENTIONAL unchanged 1,674.85 0 CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study 01/25/2022 INTERVENTIONAL unchanged 1,674.85 0 Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation 01/25/2022 INTERVENTIONAL unchanged 1,674.85 0 NextGen - Clinical Implication of Next Generation Sequencing 01/25/2022 INTERVENTIONAL unchanged 1,674.85 0 Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect 01/25/2022 INTERVENTIONAL unchanged 1,674.85 0 A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer 01/25/2022 OBSERVATIONAL unchanged 1,674.85 0 Healthy Early Life Moments in Singapore 01/26/2022 INTERVENTIONAL unchanged 1,673.85 0 Clinical Pharmacology of Dexamethasone in Pregnant Women With Preterm Labor 01/26/2022 OBSERVATIONAL unchanged 1,673.85 0 Vida Sana y Completa Obesity and Food Insecurity Study 01/27/2022 INTERVENTIONAL unchanged 1,672.85 0 Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer 01/27/2022 INTERVENTIONAL unchanged 1,672.85 0 Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks 01/28/2022 INTERVENTIONAL unchanged 1,671.85 0 Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) 01/31/2022 INTERVENTIONAL unchanged 1,668.85 0 Pregnancy at a Time That Is Happy and Healthy for You 01/31/2022 INTERVENTIONAL unchanged 1,668.85 0 Breast Reconstruction and Neoadjuvant Radiotherapy 02/01/2022 INTERVENTIONAL unchanged 1,667.85 0 Screening Women With Prior HPV for Anal Neoplasia 02/01/2022 INTERVENTIONAL unchanged 1,667.85 0 Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS) 02/01/2022 INTERVENTIONAL unchanged 1,667.85 0 Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ 02/01/2022 INTERVENTIONAL unchanged 1,667.85 0 MDMA for Co-occurring PTSD and OUD After Childbirth 02/01/2022 INTERVENTIONAL unchanged 1,667.85 0 Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) 02/02/2022 INTERVENTIONAL unchanged 1,666.85 0 Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer 02/02/2022 INTERVENTIONAL unchanged 1,666.85 0 Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome 02/02/2022 INTERVENTIONAL unchanged 1,666.85 0 Effect of Breast Implants om Mammography Screening 02/03/2022 OBSERVATIONAL unchanged 1,665.85 0 Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction 02/03/2022 INTERVENTIONAL unchanged 1,665.85 0 Platelet Rich Plasma for Uterine Scar 02/04/2022 INTERVENTIONAL unchanged 1,664.85 0 Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer 02/04/2022 INTERVENTIONAL unchanged 1,664.85 0 The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients 02/07/2022 INTERVENTIONAL unchanged 1,661.85 0 The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program 02/07/2022 INTERVENTIONAL unchanged 1,661.85 0 Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study 02/08/2022 OBSERVATIONAL unchanged 1,660.85 0 Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis 02/08/2022 INTERVENTIONAL unchanged 1,660.85 0 Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC 02/08/2022 INTERVENTIONAL unchanged 1,660.85 0 Stress Phenotypes and Preterm Birth 02/08/2022 INTERVENTIONAL unchanged 1,660.85 0 HPV-based Screening Among Women 23-29 Years of Age 02/08/2022 INTERVENTIONAL unchanged 1,660.85 0 Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer 02/09/2022 INTERVENTIONAL unchanged 1,659.85 0 How is Aerobic Exercise Compared to Localized Pain Relief Exercises in Patients With Jaw Pain and Neck Pain? 02/10/2022 INTERVENTIONAL unchanged 1,658.85 0 Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia 02/10/2022 INTERVENTIONAL unchanged 1,658.85 0 Novosyn® Quick in Patients Undergoing Episiotomy Closure 02/10/2022 OBSERVATIONAL unchanged 1,658.85 0 Validation of Scales in Reconstructive Breast Surgery 02/10/2022 OBSERVATIONAL unchanged 1,658.85 0 Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya 02/10/2022 INTERVENTIONAL unchanged 1,658.85 0 Better Lifestyle Counseling for African American Women During Pregnancy 02/10/2022 INTERVENTIONAL unchanged 1,658.85 0 A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer 02/11/2022 INTERVENTIONAL unchanged 1,657.85 0 Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer 02/11/2022 INTERVENTIONAL unchanged 1,657.85 0 Etonogestrel Implant as Emergency Contraception 02/11/2022 INTERVENTIONAL unchanged 1,657.85 0 Childhood Traumas in Obese Women: Association With Deregulation of the Glucocorticoid Axis and Inflammatory State. 02/14/2022 INTERVENTIONAL unchanged 1,654.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology